Abstract
Pregnancy confers an increased risk of both ischemic and hemorrhagic stroke, and, though uncommon, pregnancy-associated stroke is an important cause of long-term disability in young women. This chapter begins with a brief review of the physiologic and pathophysiologic features of pregnancy that contribute to stroke risk and the epidemiology of different types of stroke in pregnancy. It then moves to diagnosis and therapy. Because physicians who do not routinely treat pregnant women may shy away from decision-making due to concern for risk, it is important to emphasize the options for rapid imaging diagnosis during pregnancy. Stroke therapies have expanded greatly in recent years, and their applications demands rapid action. To provide pregnant women with the fullest opportunity to benefit from such advances, it is critical that physicians be aware of the potential therapies and their availability during pregnancy and the puerperium.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Feske SK, Klein AM. Neurology of pregnancy and the puerperium. In: Schapira A, editor. Neurology and clinical neuroscience. 1st ed. Philadelphia: Mosby Elsevier; 2007. p. 1490–503.
Feske SK, Singhal A. Cerebrovascular disorders complicating pregnancy. Continuum. 2014;20:80–99.
Clark P, Brennand J, Conkie JA, et al. Activated protein C sensitivity, protein C, protein S, and coagulation in normal pregnancy. Thromb Haemost. 1998;79:1166–70.
Wickström K, Edelstam G, Löwbeer CH, Hansson LO, Sieghahn A. Reference intervals for plasma levels of fibrinogen, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest. 2004;64:31–40.
Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MSV. Risk of thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370:1307–15.
Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecokl Reprod Biol. 1997;73:31–6.
Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768–74.
Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke. 1997;28:280–3.
Ban L, Sprigg N, Abdul Sultan A, et al. Incidence of first stroke in pregnant and nonpregnant women of childbearing age: a population-based cohort study from England. J Am Heart Assoc. 2017;6:e004601.
Sharshar T, Lamy C, Mas JL, Stroke in Pregnancy Study Group. Incidence and causes of strokes associated with pregnancy and puerperium: a study in public hospitals of Ile de France. Stroke. 1995;26:930–6.
Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy adn puerperium as evidenced in Taiwanese women. Cerebrovasc Dis. 2004;18:290–5.
Kuklina EV, Tong X, Bansil P, George MG, Callaghan WM. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern? Stroke. 2011;42:2564–70.
Chansakul T, Young GS. Neuroimaging in pregnant women. Semin Neurol. 2017;37:712–23.
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1996;333:1581–7.
Hacke W, Kaste M, Bluhmki E, ECASS Investigators, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.
Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.
Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30.
Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.
Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.
Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15:1138–47.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18.
Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877–90.
The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet. 1995;345:1455–63.
Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995;333:201–5.
Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery. 1990;27:855–65, discussion 865–856.
Einhäupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venus thrombosis. Lancet. 1991;338:597–600.
de Bruijn SFTM, Starn J, for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484–8.
Lamy C, Hamon JB, Coste J, Mas JL. Iachemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology. 2000;55:269–74.
CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343:619–29.
Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth retardation with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–14.
Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators I. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.
Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.
Dentali F, Poli D, Sconditti U, CErebral VEin Thrombosis International Study Investigators, et al. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study [published correction appears in J Thromb Haemost 2013;11:3991]. J Thromb Haemost. 2012;10:1297–302.
Saposnik G, Barinagarrementeria F, Brown RD, American Heart Association Stroke Council and the Council on Epidemiology and Prevention, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92.
Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis. 2002;13:290.
Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke. 2006;37:2168–9.
Leonhardt G, Gaul C, Nietsch HH, Buerke M. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006;21:271–6.
Murugappan A, Coplin WM, Al-Sadat AN, et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology. 2006;66:768–70.
Yamaguchi Y, Kondo T, Ihara M, et al. Intravenous recombinant tissue plasminogen activator in an 18-weeks pregnant woman with embolic stroke. Clin Neurol. 2010;50:315–9.
Hori H, Yamamoto F, Ito Y, Hashimoto Y, Hirano T, Uchino M. Intravenous recombinant tissue plasminogen activator therapy in a 14-week pregnant woman with embolic stroke due to protein S deficiency. Rinsho Shinkeigaku. 2013;53:212–6.
Tassi R, Acampa M, Marotta G, et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med. 2013;31:448e441–3.
Ritter LM, Schüler A, Gangopadhyay R, et al. Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy. J Neurol. 2014;26:632–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Feske, S.K. (2019). Stroke in Pregnancy. In: O’Neal, M. (eds) Neurology and Psychiatry of Women. Springer, Cham. https://doi.org/10.1007/978-3-030-04245-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-04245-5_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04244-8
Online ISBN: 978-3-030-04245-5
eBook Packages: MedicineMedicine (R0)